355
Views
1
CrossRef citations to date
0
Altmetric
Glaucoma

Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery

, , , , ORCID Icon, & show all
Pages 826-835 | Received 30 Jan 2023, Accepted 19 May 2023, Published online: 29 May 2023

References

  • Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–1911.
  • Cholkar K, Trinh HM, Pal D, Mitra AK. Discovery of novel inhibitors for the treatment of glaucoma. Expert Opin Drug Discov. 2015;10(3):293–313.
  • Sharpe RA, Kammerdiener LL, Williams DB, Das SK, Nutaitis MJ. Efficacy of. selective laser trabeculoplasty following incisional glaucoma surgery. Int J Ophthalmol. 2018;11(1):71–76.
  • Salim S. Current variations of glaucoma filtration surgery. Curr Opin Ophthalmol. 2012;23(2):89–95.
  • Lukowski ZL, Min J, Beattie AR, Meyers CA, Levine MA, Stoller G, Schultz GS, Samuelson DA, Sherwood MB. Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model. J Glaucoma. 2013;22(2):145–151.
  • Skuta GL, Parrish RK, 2nd. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32(3):149–170.
  • Xi X, McMillan DH, Lehmann GM, Sime PJ, Libby RT, Huxlin KR, Feldon SE, Phipps RP. Ocular fibroblast diversity: implications for inflammation and ocular wound healing. Invest Ophthalmol Vis Sci. 2011;52(7):4859–4865.
  • Fan Gaskin JC, Nguyen DQ, Soon Ang G, O'Connor J, Crowston JG. Wound healing modulation in glaucoma filtration surgery-conventional practices and new perspectives: the role of antifibrotic agents (part I). J Curr Glaucoma Pract. 2014;8(2):37–45.
  • Liu Y, Ko JA, Yanai R, Kimura K, Chikama T, Sagara T, Nishida T. Induction by latanoprost of collagen gel contraction mediated by human tenon fibroblats: role of intracellular signalling molecules. Invest Ophthalmol Vis Sci. 2008;49(4):1429–1436.
  • Meyer-ter-Vehn T, Sieprath S, Katzenberger B, Gebhardt S, Grehn F, Schlunck G. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci. 2006;47(11):4895–4904.
  • Sime PJ, O'Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol. 2001;99(3):308–319.
  • Cordeiro MF, Chang L, Lim KS, Daniels JT, Pleass RD, Siriwardena D, Khaw PT. Modulating conjunctival wound healing. Eye. 2000;14(3):536–547.
  • Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat M-L, Gabbiani G. The myofibroblast one function, multiple origins. Am J Pathol. 2007;170(6):1807–1816.
  • Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol. 2007;127(3):526–537.
  • Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Suganami H, Araie M, K-115 Clinical Study Group. Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil (K-115) combined with timolol or latanoprost: a report of 2 randomized clinical trials. JAMA Ophthalmol. 2015;133(7):755–761.
  • Koga T, Koga T, Awai M, Tsutsui J, Yue BY, Tanihara H. Rho-associated protein kinase inhibitor, Y-27632, induces alterations in adhesion, contraction and motibility in cultured human trabecular meshwork cells. Exp Eye Res. 2006;82(3):362–370.
  • Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420(6916):629–635.
  • Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhbitors. J Cardiovasc Pharmacol. 2007;50(1):17–24.
  • Wang J, Liu X, Zhong Y. Rho/Rho-associated kinase pathway in glaucoma. Int J Oncol. 2013;43(5):1357–1367.
  • Shimizu Y, Dobashi K, Iizuka K, Horie T, Suzuki K, Tukagoshi H, Nakazawa T, Nakazato Y, Mori M. Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis. Am J Respir Crit Care Med. 2001;163(1):210–217.
  • Nagatoya K, Moriyama T, Kawada N, Takeji M, Oseto S, Murozono T, Ando A, Imai E, Hori M. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 2002;61(5):1684–1695.
  • Hartmann S, Ridley AJ, Lutz S. The function of Rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease. Front Pharmacol. 2015;6:276.
  • Ko JA, Sotani Y, Ibrahim DG, Kiuchi Y. Role of macrophage migration inhibitory factor (MIF) in the effects of oxidative stress on human retinal pigment epithelial cells. Cell Biochem Funct. 2017;35(7):426–432.
  • Adachi K, Asada Y, Hirakata T, Onoue M, Iwamoto S, Kasuga T, Matsuda A. Alteration of gene expression in mice after. glaucoma filtration surgery. Sci Rep. 2020;10(1):15036.
  • Prum BE, Jr, Rosenberg LF, Gedde SJ, Mansberger SL, Stein JD, Moroi SE, Herndon LW, Jr, Lim MC, Williams RD. Primary open-angle glaucoma preferred practice pattern guidelines. Ophthalmology. 2016;123(1):P41–P111.
  • Daneshvar R, Amini N. Rho-associated kinase inhibitors: potential future treatments for glaucoma. J Ophthalmic Vis Res. 2014;9(3):395–398.
  • Lark KK, Pasha AS, Yan X, Edward DP. The effect of latanoprost and brimonidine on rabbit subconjunctival fibroblasts. J Glaucoma. 1999;8:72–76.
  • Young TL, Higginbotham EJ, Zou XL, Farber MD. Effects of topical glaucoma drugs on fistulized rabbit conjunctiva. Ophthalmology. 1990;97(11):1423–1427.
  • Honjo M, Tanihara H, Inatani M, Kido N, Sawamura T, Yue BY, Narumiya S, Honda Y. Effetcs of Rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci. 2001;42:137–144.
  • Inoue T, Tanihara H. Rho-associated kinase inhibitors: a novel glaucoma therapy. Prog Retin Eye Res. 2013;37:1–12.
  • Kitaoka Y, Kitaoka Y, Kumai T, Lam TT, Kuribayashi K, Isenoumi K, Munemasa Y, Motoki M, Kobayashi S, Ueno S. Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina. Brain Res. 2004;1018(1):111–118.
  • Hirata A, Inatani M, Inomata Y, Yonemura N, Kawaji T, Honjo M, Tanihara H. Y-27632. a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia. Graefes Arch Clin Exp Ophthalmol. 2008;246(1):51–59.
  • Futakuchi A, Inoue T, Fujimoto T, Inoue-Mochita M, Kawai M, Tanihara H. The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts. Exp Eye Res. 2016;149:107–115.
  • Kojima S, Sugiyama T, Shinji T, Ueki JD, Oku M, Ikeda HT. Effects of ripasudil, a Rho-associated protein kinase inhibitor, on conjunctival scarring in a canine filtration surgery model. Curr Top Pharma. 2015;19:67–73.
  • Mizuno Y, Okada N, Onoe H, Tokumo K, Okumichi H, Hirooka K, Kiuchi Y. Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study. BMC Ophthalmol. 2022;22(1):433.
  • Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122(1):103–111.
  • Yamanaka O, Kitano-Izutani A, Tomoyose K, Reinach PS. Pathobiology of wound healing after gluacoma filtration surgery. BMC Ophthalmol. 2015;15(S1):157.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.